(Q33873273)

29 July 2017

1 reference

title

Management of chronic lymphocytic leukaemia (English)

1 reference

29 July 2017

0 references

1 reference

2

Cheson BD

1 reference

29 July 2017

Kalil N

1

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

16

1 reference

29 July 2017

9-27

1 reference

29 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200016010-00002

29 July 2017

0 references

cites work

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00002

Deoxycoformycin in the treatment of mature B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00002

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00002

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00002

Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00002

Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism

21 January 2018

1 reference

12 December 2020

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Cancer statistics, 1998.

1 reference

12 December 2020

Prognostic factors in chronic lymphocytic leukemia

1 reference

12 December 2020

Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases.

1 reference

12 December 2020

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia

1 reference

12 December 2020

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

12 December 2020

Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia

1 reference

12 December 2020

Second cancers in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.

1 reference

12 December 2020

Splenic irradiation in chronic lymphocytic leukemia

1 reference

12 December 2020

Treatment by splenic irradiation in 22 chronic lymphocytic leukemia patients

1 reference

12 December 2020

Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.

1 reference

12 December 2020

Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.

1 reference

12 December 2020

Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia

1 reference

12 December 2020

Prolymphocytic transformation of chronic lymphocytic leukemia

1 reference

12 December 2020

Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo

1 reference

12 December 2020

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

1 reference

12 December 2020

Favorable response of early stage B CLL patients to treatment with IFN-alpha 2

1 reference

12 December 2020

Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Treatment of Chronic Lymphocytic Leukemia: A Preliminary Report of Spanish (Pethema) Trials

1 reference

12 December 2020

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

1 reference

12 December 2020

Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation

1 reference

12 December 2020

Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

12 December 2020

Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia

1 reference

12 December 2020

Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages

1 reference

12 December 2020

A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.

1 reference

12 December 2020

A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia

1 reference

12 December 2020

Presenting features and prognosis of chronic lymphocytic leukemia in younger adults

1 reference

12 December 2020

Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.

1 reference

12 December 2020

A clinicopathologic analysis of chronic lymphocytic leukemia.

1 reference

12 December 2020

Prophylactic strategies to meet infectious complications in fludarabine-treated CLL.

1 reference

12 December 2020

Hodgkin's disease variant of Richter's syndrome. Report of eight cases

1 reference

12 December 2020

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia

1 reference

12 December 2020

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

1 reference

12 December 2020

Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity

1 reference

12 December 2020

Treatment of chronic lymphocytic leukaemia with monoclonal anti-idiotypic antibody

1 reference

12 December 2020

Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield

1 reference

12 December 2020

Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia

1 reference

12 December 2020

Acute Plasma Cell Leukaemia following Chronic Lymphatic Leukaemia: Transformation or Two Separate Diseases?

1 reference

12 December 2020

Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis

1 reference

12 December 2020

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody

1 reference

12 December 2020

Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia

1 reference

12 December 2020

Chronic lymphocytic leukemia

1 reference

12 December 2020

Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation

1 reference

12 December 2020

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

12 December 2020

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response

1 reference

12 December 2020

Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia

1 reference

12 December 2020

Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia

1 reference

12 December 2020

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

12 December 2020

Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease

1 reference

12 December 2020

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

12 December 2020

2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.

1 reference

12 December 2020

Coexistence of essential thrombocythemia and chronic lymphocytic leukemia

1 reference

12 December 2020

2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

12 December 2020

A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C

1 reference

12 December 2020

Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity

1 reference

12 December 2020

Chronic lymphatic leukemia terminating in acute myeloid leukemia: review of the literature

1 reference

12 December 2020

Predictors of infection in chronic lymphocytic leukaemia (CLL)

1 reference

12 December 2020

Pure red blood cell aplasia and chronic lymphocytic leukemia

1 reference

12 December 2020

2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients.

1 reference

12 December 2020

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

12 December 2020

Subsequent Neoplasia in Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Coexistence of chronic lymphocytic leukemia and Hodgkin's disease

1 reference

12 December 2020

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features

1 reference

12 December 2020

Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia

1 reference

12 December 2020

Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis

1 reference

12 December 2020

Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, phenotypic and molecular study

1 reference

12 December 2020

Richter's syndrome: a report on 39 patients

1 reference

12 December 2020

Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. The French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Listeriosis after 2-Chlorodeoxyadenosine Treatment

1 reference

12 December 2020

Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia

1 reference

12 December 2020

Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation

1 reference

12 December 2020

Treatment of advanced chronic lymphocytic leukemia by fludarabine

1 reference

12 December 2020

2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders

1 reference

12 December 2020

Prolymphocytic leukemia. Serial responses to therapy

1 reference

12 December 2020

Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience

1 reference

12 December 2020

Association of severe and fatal infections and treatment with pentostatin

1 reference

12 December 2020

Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate

1 reference

12 December 2020

Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide

1 reference

12 December 2020

Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia

1 reference

12 December 2020

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

12 December 2020

Topotecan in chronic lymphocytic leukemia

1 reference

12 December 2020

Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

1 reference

12 December 2020

Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

12 December 2020

Fludarabine monophosphate for prolymphocytic leukaemia

1 reference

12 December 2020

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

1 reference

12 December 2020

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group

1 reference

12 December 2020

Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV)

1 reference

12 December 2020

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

1 reference

12 December 2020

Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro

1 reference

12 December 2020

A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia

1 reference

12 December 2020

[Staging classification of chronic lymphatic leukemia]

1 reference

12 December 2020

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia

1 reference

12 December 2020

Infectious and immunosuppressive complications of purine analog therapy.

1 reference

12 December 2020

Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance

1 reference

12 December 2020

High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia

1 reference

12 December 2020

Combination of Cytosine-Arabinoside (ARA-C), Cyclophosphamide and Prednisone in the Treatment of B-Chronic Lymphocytic Leukemia in Advanced Stages and Progressive Disease.

1 reference

12 December 2020

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

1 reference

12 December 2020

Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.

1 reference

12 December 2020

Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia

1 reference

12 December 2020

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

1 reference

12 December 2020

Infections in patients with chronic lymphocytic leukemia treated with fludarabine

1 reference

12 December 2020

Defective complement activity in chronic lymphocytic leukemia.

1 reference

12 December 2020

Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy

1 reference

12 December 2020

Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemia

1 reference

12 December 2020

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements.

1 reference

12 December 2020

Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

12 December 2020

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia

1 reference

12 December 2020

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma

1 reference

12 December 2020

Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy

1 reference

12 December 2020

Autoimmunity in chronic lymphocytic leukaemia

1 reference

12 December 2020

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

1 reference

12 December 2020

Nucleoside analogs in treatment of chronic lymphocytic leukemia

1 reference

12 December 2020

Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages

1 reference

12 December 2020

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

12 December 2020

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

12 December 2020

A pilot study of epirubicin and chlorambucil in the treatment of chronic lymphocytic leukemia (CLL)

1 reference

12 December 2020

Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia

1 reference

12 December 2020

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1 reference

12 December 2020

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

12 December 2020

Clinical staging of chronic lymphocytic leukemia

1 reference

12 December 2020

Reversal of autoimmune hemolytic anemia associated with chronic lymphocytic leukemia following high-dose immunoglobulin

1 reference

12 December 2020

Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia

1 reference

12 December 2020

Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Neurotoxicity of purine analogs: a review

1 reference

12 December 2020

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.

1 reference

12 December 2020

The infectious complications of chronic lymphocytic leukemia.

1 reference

12 December 2020

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group

1 reference

12 December 2020

Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin

1 reference

12 December 2020

The treatment of chronic lymphocytic leukemia with COP chemotherapy

1 reference

12 December 2020

Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases

1 reference

12 December 2020

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia

1 reference

12 December 2020

Central nervous system toxicity of fludarabine phosphate.

1 reference

12 December 2020

Pulmonary toxicity associated with fludarabine monophosphate

1 reference

12 December 2020

1 reference

12 December 2020

Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia

1 reference

12 December 2020

CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells

1 reference

12 December 2020

Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study

1 reference

12 December 2020

Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis

1 reference

12 December 2020

Complete remission in prolymphocytic leukaemia with the combination chemotherapy---CHOP

1 reference

12 December 2020

Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial

1 reference

12 December 2020

Acute lymphoblastic leukemia supervening in a case of chronic lymphocytic leukemia after continuous 3-year treatment with chlorambucil

1 reference

12 December 2020

Case/control study of the role of splenectomy in chronic lymphocytic leukemia.

1 reference

12 December 2020

Infections and serum IgG levels in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.

1 reference

12 December 2020

Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation

1 reference

12 December 2020

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

1 reference

12 December 2020

Corticosteroid-responsive pure red cell aplasia in chronic lymphatic leukemia

1 reference

12 December 2020

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia

1 reference

12 December 2020

New antimetabolites in the treatment of human malignancies

1 reference

12 December 2020

Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group

1 reference

12 December 2020

Phase I clinical trial of fludarabine phosphate (F-ara-AMP).

1 reference

12 December 2020

Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial

1 reference

12 December 2020

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

1 reference

12 December 2020

Remission of autoimmune hemolytic anemia associated with chronic lymphocytic leukemia following splenic irradiation

1 reference

12 December 2020

Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up

1 reference

12 December 2020

Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study

1 reference

12 December 2020

CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study

1 reference

12 December 2020

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia

1 reference

12 December 2020

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger

1 reference

12 December 2020

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

1 reference

12 December 2020

Second cancers in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Survival and prognostic factors in chronic lymphocytic leukemia

1 reference

12 December 2020

Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes

1 reference

12 December 2020

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

12 December 2020

2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug

1 reference

12 December 2020

Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia.

1 reference

12 December 2020

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report

1 reference

12 December 2020

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

1 reference

12 December 2020

The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ECOG study. Part I: total body irradiation-response and toxicity.

1 reference

12 December 2020

Second neoplasms in chronic lymphocytic leukemia: analysis of incidence as a function of the length of follow-up

1 reference

12 December 2020

T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule

1 reference

12 December 2020

Sustained Response of Refractory Prolymphocytic Leukemia to Fludarabine

1 reference

12 December 2020

Chronic lymphocytic leukemia: staging and prognostic factors.

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

Concurrent Cytomegalovirus and Pneumocystis Pneumonia after Fludarabine Therapy for Chronic Lymphocytic Leukemia

1 reference

12 December 2020

IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients.

1 reference

12 December 2020

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

1 reference

12 December 2020

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy

1 reference

12 December 2020

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia

1 reference

12 December 2020

10.2165/00002512-200016010-00002

Identifiers

DOI

1 reference

PubMed ID

10733261

Dimensions Publication ID

29 July 2017

1045573896

0 references

Fatcat ID

release_223zabpuwneshcutgdtfe25awm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/223zabpuwneshcutgdtfe25awm

24 November 2022

mapped directly with Wikidata item

PubMed ID

10733261

1 reference

PubMed ID

10733261